Manipulation of the gut microbiota by the use of prebiotic fibre does not override a genetic predisposition to heart failure

[1]  T. Spector,et al.  Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease , 2020, Circulation.

[2]  C. Mackay,et al.  Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension. , 2019, Hypertension.

[3]  T. Ishigami,et al.  Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI , 2019, Scientific Reports.

[4]  F. Marques,et al.  The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immune-metabolism? , 2019, Cardiovascular research.

[5]  L. T. Te Morenga,et al.  Carbohydrate quality and human health: a series of systematic reviews and meta-analyses , 2019, The Lancet.

[6]  Y. Su,et al.  Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling. , 2019, American journal of physiology. Heart and circulatory physiology.

[7]  Dian J. Cao.  Macrophages in Cardiovascular Homeostasis and Disease. , 2018, Circulation.

[8]  Haniye Sadat Sajadi,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, The Lancet.

[9]  K. Takeda,et al.  Non-Ischemic Heart Failure With Reduced Ejection Fraction Is Associated With Altered Intestinal Microbiota. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[10]  M. Dekker Nitert,et al.  Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women , 2018, Gut microbes.

[11]  Rick L. Stevens,et al.  A communal catalogue reveals Earth’s multiscale microbial diversity , 2017, Nature.

[12]  T. Vos,et al.  Global, regional, and national incidence and prevalence, and years lived with disability for 328 diseases and injuries in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .

[13]  Francesca Sperati,et al.  Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy , 2017, Cancer biology & therapy.

[14]  S. Hazen,et al.  Gut Microbiota in Cardiovascular Health and Disease , 2017, Circulation research.

[15]  L. Räber,et al.  Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors , 2017, European heart journal.

[16]  A. El-Osta,et al.  High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice , 2017, Circulation.

[17]  M. Hattori,et al.  Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure , 2017, PloS one.

[18]  Baohua Xu,et al.  Inhibitory effect and mechanism of exogenous mammalian sterile 20-like kinase 1 on the growth of human colorectal cancer , 2017, Oncology letters.

[19]  P. Wilmes,et al.  A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility , 2016, Cell.

[20]  G. Fonarow,et al.  Epidemiology and aetiology of heart failure , 2016, Nature Reviews Cardiology.

[21]  J. Marín-García.  Cell death in the pathogenesis and progression of heart failure , 2016, Heart Failure Reviews.

[22]  W. Tang,et al.  Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis. , 2015, Journal of cardiac failure.

[23]  Ting Chen,et al.  YAP and TAZ Take Center Stage in Cancer. , 2015, Biochemistry.

[24]  Robert J. Moore,et al.  Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites , 2015, Nature Communications.

[25]  G. Gloor,et al.  Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat , 2014, Circulation. Heart failure.

[26]  S. Hazen,et al.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.

[27]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[28]  E. Schiffrin,et al.  T Regulatory Lymphocytes Prevent Angiotensin II–Induced Hypertension and Vascular Injury , 2011, Hypertension.

[29]  P. Poole‐Wilson,et al.  Altered intestinal function in patients with chronic heart failure. , 2007, Journal of the American College of Cardiology.

[30]  N. Hagiwara,et al.  Increases in circulating T lymphocytes expressing HLA-DR and CD40 ligand in patients with dilated cardiomyophthy , 2007, Heart and Vessels.

[31]  M. Lindsay,et al.  Mammalian Sterile20-like kinase 1 and the regulation of apoptosis. , 2004, Biochemical Society transactions.

[32]  S. Frøland,et al.  Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. , 2003, Cardiovascular research.

[33]  S. Vatner,et al.  Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. , 2003, The Journal of clinical investigation.

[34]  J. Chernoff,et al.  The Ste20-like Protein Kinase, Mst1, Dimerizes and Contains an Inhibitory Domain* , 1996, The Journal of Biological Chemistry.

[35]  C. Mackay,et al.  Diet, gut microbiota and immune responses , 2010, Nature Immunology.

[36]  B. Andersson,et al.  Impaired activation of IFN-gamma+CD4+ T cells in peripheral blood of patients with dilated cardiomyopathy. , 2010, Cellular immunology.

[37]  上野 敦子.  Increases in circulating T lymphocytes expressing HLA-DR and CD40 ligand in patients with dilated cardiomyopathy , 2007 .